Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Post by Ricky55on Jun 11, 2013 9:32am
194 Views
Post# 21510253

Message for thoses who worry a bit!

Message for thoses who worry a bit!

I was little worry about my investment at Nox a couple of weeks ago when the share price was around $0.15

and i had an e-mail chat with the invesment relation person at Nox.That's why i will stay long in NOX.Here is what he told me:

We have close to $6,000,000 in the bank and a burn rate of less than $1,000,000 per year, so we are fine financially. We have over 2,000,000 oz gold deposit that is worth much more than where we are trading. Our partners Hecla/Aurizon may still continue with the development program which means they would have to fund another $9,000,000 before September. If they do not then we retain 100% of the deposit and received $9,000,000 from Aurizon already without issuing any shares (no dilution). I think NOX has done a great job to develop the asset at limited dilution to shareholders. If gold has bottomed (I think it has) then markets will improve by the fall and even without Hecla several other mining companies are interested in our property. Hang in there, things will improve.

 

Regards,

<< Previous
Bullboard Posts
Next >>